Candesartan Amlodipin Sandoz 8 mg/5 mg
Candesartan Amlodipin Sandoz 8 mg/5 mg is a medicine authorised by Swissmedic under authorisation number 68860. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 June 2024 and the authorisation is limited until 05 June 2029. ATC code C09DB07 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 68860 |
|---|---|
| Name | Candesartan Amlodipin Sandoz 8 mg/5 mg |
| Full name | Candesartan Amlodipin Sandoz 8 mg/5 mg , Hartkapseln |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DB07 |
| First authorisation | 06 June 2024 |
| Authorisation validity | 05 June 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Candesartan Amlodipin Sandoz 8 mg/5 mg , Hartkapseln | B | 06 June 2024 |
| 2 | Candesartan Amlodipin Sandoz 8 mg/10 mg, Hartkapseln | B | 06 June 2024 |
| 3 | Candesartan Amlodipin Sandoz 16 mg/5 mg, Hartkapseln | B | 06 June 2024 |
| 4 | Candesartan Amlodipin Sandoz 16 mg/10 mg, Hartkapseln | B | 06 June 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 2 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 3 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 4 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 5 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 6 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 7 | 28 | Kapsel(n) | C09DB07 | 02.07.1. | B |
| 8 | 98 | Kapsel(n) | C09DB07 | 02.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Candesartan Amlodipin Sandoz 8 mg/5 mg authorised in Switzerland?
Yes. Candesartan Amlodipin Sandoz 8 mg/5 mg is authorised by Swissmedic under authorisation number 68860, data as of 01 September 2026. The authorisation is limited until 05 June 2029.
Which dispensing category does Candesartan Amlodipin Sandoz 8 mg/5 mg have?
Candesartan Amlodipin Sandoz 8 mg/5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Candesartan Amlodipin Sandoz 8 mg/5 mg?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.